Sort
46,585 grants matching “heart failure”
A new DMD model with a humanized glycome
$521,787Paul Taylor Martin · Research Inst Nationwide Children'S Hosp · R01 · FY2015 · AR
Impact of Insufficient Vascular EC-SOD in Pulmonary Hypertension
$521,781Eva Nozik Grayck · University Of Colorado Denver · R01 · FY2015 · HL
Determining the Role of Junctophilin-2 in Cardiac Disease
$521,718Xander H.t. Wehrens · Baylor College Of Medicine · R01 · FY2017 · HL
Determining the Role of Junctophilin-2 in Cardiac Disease
$521,718Xander H.t. Wehrens · Baylor College Of Medicine · R01 · FY2014 · HL
PROJECT I; POLYGENIC CAUSES of ISOLATED and NON-SYNDROMIC CONGENITAL
$521,683Patricia K Donahoe · Massachusetts General Hospital · P01 · FY2015 · HD
Mediterranean diet, Metabolites, and Cardiovascular Disease
$521,672Frank B Hu · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · HL
Peer Support--Congestive Heart Failure Self-Management
$521,666Mary Ellen Michele Heisler · University Of Michigan At Ann Arbor · R01 · FY2006 · HL
Pharmacologic Treatment of Mitochondrial Complex I Dysfunction in C. Elegans
$521,578Marni J Falk · Children'S Hosp Of Philadelphia · R01 · FY2018 · GM
Pharmacologic Treatment of Mitochondrial Complex I Dysfunction in C. Elegans
$521,578Marni J Falk · Children'S Hosp Of Philadelphia · R01 · FY2019 · GM
Localized Targeting of Matrix Proteases Following Myocardial Infarction
$521,538Francis G Spinale · University Of South Carolina At Columbia · R01 · FY2014 · HL
Endothelium-driven signaling network in the development of pulmonary hypertension
$521,533Hua Linda Cai · University Of California Los Angeles · R01 · FY2022 · HL
Endothelium-driven signaling network in the development of pulmonary hypertension
$521,533Hua Linda Cai · University Of California Los Angeles · R01 · FY2023 · HL
Investigating Cellular Immunometabolic Mechanisms Underlying HIV-Related Cardiovascular Disease Risk
$521,525Michael Jay Corley · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · HL
Regulation of CSE-Derived Hydrogen Sulfide in the Heart
$521,524John Winter Calvert · Emory University · R01 · FY2023 · HL
Randomized Trial of Nonflouroscopic Technologies in Pediatric SVT Ablation
$521,500Jane W. Newburger · Boston Children'S Hospital · U10 · FY2011 · HL
Mechanisms Connecting Dysregulated Branched-Chain Alpha-Ketoacid Metabolism to Cardiac Dysfunction
$521,482Robert Walker McGarrah · Duke University · R01 · FY2022 · HL
Cognitive Intervention to Improve Memory in Heart Failure Patients
$521,466Susan J Pressler · Indiana University Indianapolis · R01 · FY2019 · NR
System factors influencing the postpartum transition to primary care for cardiovascular disease risk management among women with hypertensive disorders in pregnancy
$521,460Kimberley Lynn H Geissler · Baystate Medical Center, Inc. · R01 · FY2025 · HL
In Vitro and In Situ Engineering of Fibroblasts for Cardiac Repair
$521,375Nenad Bursac · Duke University · R01 · FY2019 · HL
Reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose
$521,375Janet D Pierce · University Of Kansas Medical Center · R01 · FY2019 · AG
Endothelium-driven signaling network in the development of pulmonary hypertension
$521,357Hua Linda Cai · University Of California Los Angeles · R01 · FY2021 · HL
Resilience, cultural alignment, and social support in brain aging: Data from the Strong Heart Study
$521,320Astrid M Suchy-Dicey · Washington State University · R01 · FY2020 · AG
Gene Therapy for Long-Term Myocardial Protection
$521,290Victor J Dzau · Duke University · R01 · FY2009 · HL
Regression of cardiac hypertrophy
$521,276Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · HL
Aldosterone, nitric oxide, myocardial fibrosis, and capillary loss in ESRD
$521,271David M Charytan · Brigham And Women'S Hospital · U01 · FY2014 · DK